$XERS XERIS PHARMACEUTICALS INC Insider Trading
Get free email notifications about insider trading in XERIS PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in XERIS PHARMACEUTICALS INC. Insider overview, share value development, latest insider transactions and email notifications about new events in XERIS PHARMACEUTICALS INC for free.
CIK Number: 0001346302
IRS Number: 203352427
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: XERS
Company Address: 180 NORTH LASALLE STREET SUITE 1600 CHICAGO 60601
Phone number: 512-498-2670
XERIS PHARMACEUTICALS INC Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 08 2021 | XERS | XERIS PHARMACEUTIC ... | BORMANN-KENNEDY BARBARA-JEAN A ... | Director | Option Exercise | A | 3.90 | 11,228 | 43,789 | 11,228 | |
Apr 13 2021 | XERS | XERIS PHARMACEUTIC ... | PRESTRELSKI STEVEN | Chief Scientific Of ... | Sell | S | 4.07 | 10,000 | 40,725 | 496,824 | 506.8 K to 496.8 K (-1.97 %) |
Feb 01 2021 | XERS | XERIS PHARMACEUTIC ... | Edick Paul R | See Remarks | Option Exercise | A | 5.08 | 400,000 | 2,032,000 | 400,000 | |
Feb 01 2021 | XERS | XERIS PHARMACEUTIC ... | Edick Paul R | See Remarks | Grant | A | 0.00 | 225,000 | 0 | 636,134 | 411.1 K to 636.1 K (+54.73 %) |
Feb 01 2021 | XERS | XERIS PHARMACEUTIC ... | Shannon John Patrick Jr | See Remarks | Grant | A | 0.00 | 150,000 | 0 | 271,224 | 121.2 K to 271.2 K (+123.74 %) |
Feb 01 2021 | XERS | XERIS PHARMACEUTIC ... | PRESTRELSKI STEVEN | Chief Scientific Of ... | Grant | A | 0.00 | 100,000 | 0 | 506,824 | 406.8 K to 506.8 K (+24.58 %) |
Feb 01 2021 | XERS | XERIS PHARMACEUTIC ... | JOHNSON KENNETH ERLAND | See Remarks | Grant | A | 0.00 | 65,000 | 0 | 91,890 | 26.9 K to 91.9 K (+241.73 %) |
Feb 01 2021 | XERS | XERIS PHARMACEUTIC ... | Hecht Beth | See Remarks | Grant | A | 0.00 | 150,000 | 0 | 210,814 | 60.8 K to 210.8 K (+246.65 %) |
Feb 01 2021 | XERS | XERIS PHARMACEUTIC ... | Deutsch Barry M. | See Remarks | Grant | A | 0.00 | 115,000 | 0 | 208,090 | 93.1 K to 208.1 K (+123.54 %) |
Jan 15 2021 | XERS | XERIS PHARMACEUTIC ... | PRESTRELSKI STEVEN | Chief Scientific Of ... | Sell | S | 6.01 | 10,000 | 60,058 | 406,824 | 416.8 K to 406.8 K (-2.40 %) |
Jan 12 2021 | XERS | XERIS PHARMACEUTIC ... | PRESTRELSKI STEVEN | Chief Scientific Of ... | Sell | S | 5.72 | 10,000 | 57,244 | 416,824 | 426.8 K to 416.8 K (-2.34 %) |
Dec 17 2020 | XERS | XERIS PHARMACEUTIC ... | PRESTRELSKI STEVEN | Chief Scientific Of ... | Gift | G | 0.00 | 10,000 | 0 | 426,824 | 436.8 K to 426.8 K (-2.29 %) |
Dec 10 2020 | XERS | XERIS PHARMACEUTIC ... | Edick Paul R | See Remarks | Buy | P | 4.06 | 10,000 | 40,551 | 411,134 | 401.1 K to 411.1 K (+2.49 %) |
Dec 10 2020 | XERS | XERIS PHARMACEUTIC ... | Edick Paul R | See Remarks | Buy | P | 4.06 | 10,000 | 40,551 | 411,134 | 401.1 K to 411.1 K (+2.49 %) |
Aug 20 2020 | XERS | XERIS PHARMACEUTIC ... | Shannon John Patrick Jr | See Remarks | Option Exercise | A | 4.29 | 100,000 | 429,000 | 100,000 |